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Summary Although breast carcinomas are considered to originate from glandular epithelial cells, some exhibit 'squamoid features',
comprising stratification with a gradient in the nuclear-cytoplasmic ratio within individual cancer cell nests on microscopy. In parallel with a
histological review of squamoid features, we immunohistochemically investigated the expression of involucrin, a marker of terminal squamous
differentiation, in 223 breast carcinomas with one to three regional nodal metastases but no distant metastases and analysed their
association with other clinicopathological parameters to explore their clinical and biological implications. Squamoid features and involucrin
expression, detected in 22% and 27% of cases respectively, correlated with each other and were associated with high-grade atypia, a solid-
nest pattern, cancer cell necrosis on histology and negative oestrogen receptor status. The incidence of regional recurrences was higher in
patients with involucrin expression, whereas bone metastases were less frequent in groups with squamoid features or with diffuse (> 10%)
involucrin expression. Both squamoid features and involucrin expression, which were considered to be derived either from differentiation into
keratinocytes or from some kind of cellular degeneration caused by high turnover rate, are suggested to influence the biological behaviour of
breast cancer cells in vivo, and they may be effective in predicting the most likely recurrence sites.
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Most carcinomas arising in mammary glands, e.g. invasive ductal
carcinoma (IDC), invasive lobular carcinoma (ILC) and mucinous
carcinoma, are categorized as adenocarcinomas. Even in IDC,
however, there is a wide spectrum of histological structures
ranging from tubular or papillary patterns to solid-nest or strand
patterns, with or without extracellular or cytoplasmic mucus
production. Squamous metaplasia, defined by the presence of
intercellular bridges and/or keratinization, is also reported to occur
in ductal carcinoma (Fisher et al, 1975). In the field of gynaeco-
logical pathology, in addition to intercellular bridges and kera-
tinization, the presence of at least three of the following four
criteria is accepted as evidence of squamous differentiation: (1)
sheet-like growth without gland formation or palisading; (2) sharp
cell margins; (3) eosinophilic and thick or glassy cytoplasm; and
(4) a decreased nuclear/cytoplasmic ratio compared with foci else-
where in the same tumour (Silverberg and Kurman, 1992).
Although such squamoid features are often encountered micro-
scopically in breast carcinomas during routine diagnostic practice,
their clinical and diagnostic significance is still unclear.
Several molecules are involved in the differentiation of squa-
mous epithelial cells, including involucrin, filaggrin, loricrin, etc.
(Rice and Green, 1979; Watt and Green, 1981; Lynley and Dale,
1983; Mehrel et al, 1990). Involucrin is a cytoplasmic 92-kDa
protein that becomes cross-linked to other proteins by acting as a
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substrate for transglutaminase during the terminal differentiation
of keratinocytes (Rice and Green, 1979; Watt and Green, 1981).
Antibodies against the molecules operating in squamoid differenti-
ation have been used to examine alterations in their expression in
various tumour types (Warhol et al, 1982; Said et al, 1983; Murphy
et al, 1984). An immunohistochemical study in breast cancer also
revealed that involucrin expression was frequent in IDC,
medullary and intraductal carcinomas (Schmid et al, 1993). To
reveal clinical and biological implications of squamoid features in
breast cancer cells, we reviewed haematoxylin-eosin-stained
tissue sections to identify stratification of cancer cell nests and
immunohistochemically investigated the expression of involucrin
in 223 primary breast cancers with a nearly identical degree of
local spread. The association of squamoid features and involucrin
expression with histological parameters, e.g. structural patterns,
necrosis, histological grade of atypia and clinical outcome of the
patients, in particular recurrence sites, was studied.
MATERIALS AND METHODS
Patient data
To avoid any effect of the degree of local tumour spread on the
type of recurrence site, we selected breast cancer patients with
metastases in one to three axillary lymph nodes. We were able to
obtain formalin-fixed, paraffin-embedded blocks of breast cancer
tissue from 223 ofthe 265 consecutive breast cancer patients who
underwent standard or modified radical mastectomies at the
National Cancer Center Hospital, Tokyo, between 1980 and 1984
and who were microscopically diagnosed as having metastases in
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Figure i Light microscopic presentation of squamoid features in breast carcinoma. (A-C) IDCs with solid-nest patterns. Gradients in the nuclear/cytoplasmic
ratio are seen in the cells constituting the nests. In B, coagulation necrosis are observed. (D) An IDC exhibiting squamoid features in the cell nests involved in
the fibrous area. (x 200, haematoxylin-eosin stain)
one to three regional lymph nodes. Distant metastases in the
lung/pleura, bone or liver were ruled out in all cases by preopera-
tive chest roentgenography, bone scintigraphy and laboratory
examination of serum.
Data were acquired from individual medical charts for tumour
size on palpation, the number of regional metastases, oestrogen
receptor (OR) status, overall and disease-free survival after
mastectomy, cause ofdeath and the first and any subsequent recur-
rence sites detected clinically and/or by imaging during follow-up.
The recurrence sites were categorized into two: (1) regional recur-
rences, including local recurrence in the skin and/or chest wall and
metastasis to the ipsilateral supraclavicular or cervical lymph
nodes; and (2) distant metastases, composed of five subclassifica-
tions - lung and/or pleura, bone, liver, brain and others.
Histological examinations
Histological type and grade, structural pattern, necrosis and the
presence ofsquamoid features were examined by light microscopy
in haematoxylin-eosin-stained tissue specimens from each
tumour. Histological typing of individual tumours was performed
according to the criteria ofthe World Health Organization classifi-
cation (Scarff and Torloni, 1968).
The specimens were also categorized into three histological
grades: grade 1 (low-grade atypia), grade 2 (intermediate-grade
atypia) and grade 3 (high-grade atypia) (Tsuda et al, 1990a). This
grading system was mostly in accordance with those ofBloom and
Richardson (1957) and Elston (1987), except for the following
points: (1) the grading was applied to all histological types; (2) on
scoring the degree of architectural atypia, not only tubular pattern
but also papillary pattern were taken into account; (3) the scoring
of the number of mitotic figures was modified - score 1 for < 5
mitotic figures per 10 high-power fields (x 400), score 2 for 5-10
mitotic figures per 10 high-power fields and score 3 for > 10
mitotic figures per 10 high-power fields; and (4) the assessment of
the summed scores of architectural atypia, nuclear atypia and the
number of mitotic figures was modified - scores of 3 and 4 were
regarded as grade I and scores of5-7 as grade 2.
They were also classified microscopically into four structural
patterns that were dominant in the invasive component of indi-
vidual tumours: (1) tubular pattern, which contained tubular
and/or cribriform structure; (2) strand pattern, in which cancer
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Figure 2 Involucrin expression in breast carcinomas. Involucrin expression
is seen in IDCs with solid-nest patterns. Cytoplasmic immunoreaction is seen
in cells with a low nuclear/cytoplasmic ratio in the nest (A) and in cells
involved in fibrous area (B). (x 200, immunoperoxidase stain)
cells infiltrated in a strand and/or single-cell manner; (3) solid-nest
pattern, which contained wide and regular or irregular nests with
or without massive necrosis; and (4) papillary pattern, in which
papillary structure with fibrous stalks and/or pseudopapillary
structure without the stalks was observed.
We regarded stratification with a gradient between the periph-
eral and central zones in each cancer cell nest as indicating
'squamoid features'; the peripheral zone is composed of small
cells with a high nuclear-cytoplasmic ratio, whereas the central
zone is characterized by larger cells with low nuclear-cytoplasmic
ratio, clear intercellular borders and eosinophilic and thick or
glassy cytoplasm. Coagulation necrosis in tumourcells wasjudged
positive only when necrosis was present in the invasive com-
ponents. Necrosis in the intraductal component was not taken into
consideration in the present study.
Immunohistochemistry
Immunohistochemistry was performed on routinely processed
formalin-fixed, paraffin-embedded tissue using an avidin-biotin-
peroxidase complex method (Hsu et al, 1981; Tsuda et al, 1990b)
Table 1 Association between histological squamoid features and involucrin
expression in breast carcinoma
No. of specimens (%)
Total Involucrin expression
++ (210%) + (< 10%) _
Squamoid features
Positive 49 15 (29) 13 (27) 21 (44)a1
Negative 174 11 (6) 21 (12) 142 (82)1
Total 223 26 34 163
ap< 0.001.
with an anti-involucrin rabbit polyclonal antibody (Biomedical
Technologies, Stoughton, MA, USA), which had been shown to
detect specifically a 92-kDa band in lysates of keratinocytes by
biochemical analyses (Rice and Green, 1979; Watt and Green,
1981), as a primary antibody at a dilution of 1:10. Specimens were
classed as negative, positive in < 10% or positive in 2 10% of
invasive cancer cells, according to the number of cells with
cytoplasmic staining. Staining of cancer cells in the intraductal
component was not counted.
Statistical analysis
The associations between parameters were analysed using the chi-
squared test or Fisher's exact test. Survival curves for patient
groups were compiled by the Kaplan-Meier method and differ-
ences were compared by the log-rank test (Kaplan and Meier,
1958; Peto et al, 1977).
RESULTS
Association of squamoid features and involucrin
expression with other clinicopathological parameters
Squamoid features were observed in 49 (22%) of 223 carcinomas:
23% ofIDC, 0% ofILC, 50% ofmedullary carcinomas and in one
squamous cell carcinoma. Squamoid features were observed in
both individual solid nests and in cells forming strands that are
involved in the fibrous or collagenous stroma at the tumour centre
(Figure lA-D). Involucrin was expressed in 60 (27%) breast carci-
nomas: 26% of IDC, 15% of ILC, all four medullary carcinomas
and one squamous cell carcinoma. In 26 specimens, involucrin
was positive in . 10% ofcancercells. In each case, skin epidermis,
as an internal control, was shown to be positive for immunoreac-
tion. Involucrin expression was mostly detected in solid nests of
cancer cells showing a low nuclear/cytoplasmic ratio, eosinophilic
or glassy cytoplasm, and clear intercellular borders (Figure 2).
Several specimens showed expression in cancer cells involved in
the fibrous or collagenous area at the tumour centre where these
cells were sparsely distributed as if they were left in the stroma
(Figure 2).
Squamoid features were significantly correlated with the degree
ofinvolucrin expression (Table 1) and were observed significantly
more frequently in tumours with a solid-nest pattern (47%), grade
3 tumours (33%), tumours positive for necrosis (64%), tumour size
> 2.1 cm (29%) and negative OR status (29%), but were not asso-
ciated with the number of metastatic lymph nodes (Table 2). The
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Table 2 Association of squamoid features and involucrin expression with
clinicopathological parameters in invasive breast carcinomas
Parameters Number of specimens (%)
Total Squamoid P-value Involucrin P-value
features expression
Histological type
IDC 204 46 (23) 53 (26)
ILC 13 0 (0) 2 (15)
Medullary 4 2 (50) 4 (100)
Carcinoma with metaplasia
Squamous cell 1 1 (100) 1 (100)
Spindle cell 1 0 (0) 0 (0)
Structural pattern
Solid-nest 94 44 (47) < 0.001 37 (39) <0.001
Strand 77 4 (5) 15 (19)
Tubular 45 1 (2) 6 (13)
Papillary 7 0 (0) 2 (29)
Histological grade
1 or2 89 5 (6) 1 <0.001 11 (12)1 <0.001
3 133 44 (33) J 49 (37) J
Cancer cell necrosis
Present 56 36 (64) < 0.001 32 (57) < 0.001
Absent 167 13 (8) J 28 (17) J
Tumour size (cm)
<2.0 90 10 (11) < 0.001 20 (22) NS
.2.1 133 39 (29) 40 (30)
OR status
Positive 68 9(13) <0.05 9(13)1 <0.001
Negative 62 18 (29) 1 25 (40) J
Not examined 93 22 (24) 26 (28)
Number of
regional lymph node metastases
1 117 23 (20) NSa 33(28) NS
2 62 14 (23) 15 (24)
3 44 12 (27) 12 (27)
Total 223 49 (22) 60 (27)
IDC, invasive ductal carcinoma; ILC, invasive lobular carcinoma. aNS, not
significant.
incidence ofinvolucrin expression was also significantly higher in
tumours of the solid-nest type (39%), grade 3 tumours (37%),
necrosis (57%) and negative OR (40%), but was not associated
with the number ofregional lymph node metastases ortumour size
(Table 2).
Association of squamoid features and involucrin
expression with recurrence sites
Forty-nine patients suffered a recurrence of their breast cancer
within 7.2 years after initial surgical therapy, and 29 ofthese died
of disseminated cancer within 12.8 years after surgery. Other
patients with recurrence comprised eight who died of unknown
causes, three who died from other diseases and nine who remain
alive 7.3-15.1 years after surgery. The median follow-up period in
the 183 patients who are still alive with or without recurrence is
11.0 years.
There were no significant differences in disease-free or overall
survival curves between the patient groups with or without
squamoid features, or between those with and without involucrin
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Figure 3 Survival curves for breast cancer patients with one to three regional
lymph node metastases at study entry. (A) Disease-free survival curves; (B)
overall survival curves. Curves for patient groups with involucrin expression
in 2 10% of cancer cells (a), with involucrin expression in < 10% of the cancer
cells (b), and with no expression (c). There were no statistically significant
differences between the curves, although there was a tendency towards a
higher recurrence rate in the involucrin-positive groups
Table 3 Association of recurrence sites with squamoid features and
involucrin expression in primary breast carcinomas
Total Number of patients with recurrence (%)
Total Recurrence sites
Bone Lung/ Local Liver Brain Othersa
pleura
Squamoid features
Present 49 12 2 (4)b 1 8 (16) 6 (12) 4 (8) 1 (2) 0 (0)
Absent 174 37 23 (13)] 15 (9) 11 (6) 12 (7) 3 (2) 5 (3)
Involucrin expression
++ (.10%) 26 6 0 (o)c 3 (12)
+ (< 10%) 34 11 7 (21) 5 (15)
- 163 32 18(11)] 15(9)
4 (15)dl 3 (12) 0 (0) 0 (0)
5 (15) i 2 (6) 0 (0) 0 (0)
8 (5) J11 (7) 4 (2) 5 (3)
aOthers comprised four contralateral breast metastases and one metastasis
to back skin. bp= 0.05; cp = 0.037; dp< 0.01.
expression, although there was a slight tendency towards a higher
recurrence rate in patients positive for involucrin (Figure 3).
Further metastases were detected in a total of 90 sites in 49
patients during follow-up, the number of sites varying from one to
four per patient. Bone metastases arose in 13%, 21% and 11% of
patients with tumours exhibiting no squamoid features, involucrin
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expression in < 10% ofcells and no involucrin expression, respec-
tively, but they were detected in only 4% and 0% of patients with
tumours showing squamoid features (P = 0.05) and diffuse (. 10%)
involucrin expression (P = 0.037) respectively (Table 3). On the
other hand, local recurrences tended to occur more frequently in
groups with tumours showing squamoid features (12%) or involu-
crin expression (15%) than in those without squamoid features
(6%) or involucrin expression (5%) (P < 0.01). Lung/pleural
metastases also tended to occur more frequently in groups with
squamoid features or involucrin expression, although there was no
statistically significant difference (Table 3).
DISCUSSION
The present study showed that more than 20% ofcommon types of
breast carcinomas reveal squamoid features, i.e. stratification with
a gradient in the nuclear-cytoplasmic ratio in each cancer nest.
Squamoid features corresponded with the expression of involu-
crin, a specific marker forterminal differentiation ofkeratinocytes,
in a large number of cases. The squamoid features defined in this
study differed from the squamous cell-like differentiation used by
Schmid et al (1993) because we used that term in a broader sense
from the viewpoint that it was unknown whether the squamoid
features stand for true differentiation toward squamous epithelium
or not. Squamoid features and involucrin expression also corre-
lated with high-grade atypia, a solid-nest pattern, tumour necrosis
and negative OR status in breast cancer cells. From its definition, a
high histological grade of atypia is characterized by marked
nuclear pleomorphism in size and shape, increased mitosis and
loss of glandular structure (Bloom and Richardson, 1957; Elston,
1987). Therefore, in most breast carcinoma cases with squamoid
features, rapid cell proliferation and cell death appear to be
constantly ongoing processes, and the characteristic morphology
and expression of OR of the precursor glandular cells appear to
have been mostly lost.
Necrosis could occur by either of the mechanisms of cell death
resulting from programmed apoptosis; these include cell death
associated with squamous differentiation or that resulting from
accidental ischaemia occurring in the centre of individual cancer
cell nests (Majno and Joris, 1995). It is also shown that the number
of apoptotic cancer cells is higher in tumours showing high-grade
atypia and necrosis (Lipponen et al, 1994).
The squamoid features and involucrin expression observed in
these breast carcinomas were thus considered to result from either
true differentiation of the cancer cells into keratinocytes or from
massive cell death, probably due to ischaemia, caused by the high
turnover rate of the cancer cells, i.e. rapid cell division and death.
As these findings occurred most commonly in grade 3 carcinomas
showing a solid-nest growth pattern but without keratinization on
microscopy, the majority of the breast carcinomas showing
squamoid features and/or involucrin expression would be likely to
be derived from some kind of cellular degeneration associated
with the high turnover rate ofthe cancer cells rather than from true
differentiation into epidermal keratinocytes.
In ILC, 15% of tumours expressed involucrin. Schmid et al
(1993) also reported that involucrin was expressed in one of 11
ILCs. The significance ofthese findings remains to be studied.
It is well known that biological behaviour differs markedly
between squamous cell carcinomas and adenocarcinomas arising
in certain organs, e.g. lung. In a study of lung cancer tissue from
autopsy material, the frequency of distant metastases was much
lower for squamous cell carcinoma than for adenocarcinoma
(Carter and Eggleston, 1980). Although squamoid features and
involucrin expression in breast carcinoma might not represent true
differentiation toward squamous cell carcinoma as described
above, the most common recurrence sites differed, or had a
tendency to differ, between breast carcinomas with and without
squamoid features and in accordance with the percentage of
involucrin expression, with regard to bone, local and lung/pleural
recurrences. Tumours with these features tended to produce local
recurrences and/or metastases in the lung/pleura. On the other
hand, breast cancers with no squamoid features or weak or no
involucrin expression tended to result in bone metastases.
It has been shown that the anatomical distribution of metastases
varies with nuclear atypia and the status of steroid receptors
(Kamby et al, 1988). Visceral metastases occur more frequently
with tumours showing high-grade atypia, whereas bone metastases
occur preferentially with steroid receptor-rich group tumours,
regardless of their histological grade. Expression of the para-
thyroid hormone-related protein (PTHrP) gene has also been
suggested to be associated with bone metastases in breast carci-
noma (Bouizar et al, 1993). In order to choose the most appro-
priate therapy for patients with recurrent breast carcinoma, early
detection of recurrence sites is mandatory. Examination of the
squamoid features and involucrin expression at the primary site, as
well as histological atypia, steroid receptors and PTHrP, may
therefore be helpful in predicting the most likely recurrence sites.
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IDC, invasive ductal carcinoma; ILC, invasive lobular carcinoma;
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